RTHP-20. MULTI-INSTITUTIONAL ANALYSIS OF HIGH-RISK WHO GRADE II OLIGODENDROGLIOMA TREATED WITH ADJUVANT RADIOTHERAPY PLUS TEMOZOLOMIDE (TMZ) VERSUS PROCARBAZINE, LOMUSTINE, AND VINCRISTINE (PCV)

PURPOSE: To compare outcomes of adults with high-risk grade II oligodendroglioma treated with adjuvant radiotherapy plus adjunctive TMZ versus PCV. METHODS: We queried a multi-institutional database from the Cleveland Clinic and Mayo Clinic of 158 adults with WHO grade II glioma who were high-risk (...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Tom, Martin, Routman, David, Laack, Nadia, Frechette, Kelsey, Park, Deborah, (Auston) Wei, Wei, Leyrer, Marc, Peereboom, David, Ahluwalia, Manmeet, Chao, Samuel, Suh, John, Murphy, Erin
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Radiation Therapy
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847387/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.891
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars